HFG
CVS icon

Heron Financial Group’s CVS Health CVS Stock Holding History

Heron Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$391K Sell
5,657
-179
-3% -$12.7K 0.21% 96
2023
Q1 		$434K Sell
5,836
-145
-2% -$12.2K 0.24% 87
2022
Q4 		$541K Sell
5,981
-100
-2% -$9.65K 0.36% 60
2022
Q3 		$580K Buy
6,081
+100
+2% +$9.9K 0.36% 63
2022
Q2 		$554K Sell
5,981
-200
-3% -$19.5K 0.34% 69
2022
Q1 		$626K Sell
6,181
-185
-3% -$19.4K 0.33% 69
2021
Q4 		$677K Buy
6,366
+430
+7% +$39.7K 0.36% 62
2021
Q3 		$504K Hold
5,936
– – 0.28% 78
2021
Q2 		$495K Hold
5,936
– – 0.28% 79
2021
Q1 		$441K Sell
5,936
-18
-0.3% -$1.31K 0.27% 84
2020
Q4 		$441K Sell
5,954
-466
-7% -$30.3K 0.3% 74
2020
Q3 		$378K Buy
6,420
+2,043
+47% +$127K 0.3% 78
2020
Q2 		$274K Sell
4,377
-105
-2% -$6.61K 0.25% 94
2020
Q1 		$276K Sell
4,482
-426
-9% -$28.4K 0.28% 84
2019
Q4 		$362K Buy
+4,908
New +$345K 0.3% 83

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Heron Financial Group's CVS Position: Q2 2023 in Review

Heron Financial Group reduced its CVS Health (CVS) stake by 3.1% in Q2 2023, selling an estimated $12.7K and leaving 5,657 shares worth $391K. The position accounts for 0.21% of the portfolio, ranked #96.

Heron Financial Group first reported a position in CVS in Q4 2019 and has held it in 15 quarters since. The position peaked at $677K in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Heron Financial Group held 5,657 shares of CVS Health worth $391K as of Q2 2023.
  • Heron Financial Group sold 179 CVS Health shares in Q2 2023, an estimated $12.7K.
  • CVS Health made up 0.21% of Heron Financial Group's portfolio in Q2 2023, its #96 holding.
  • Heron Financial Group first reported a position in CVS Health in Q4 2019 and has held it in 15 quarters since.
  • Heron Financial Group's CVS Health position peaked at $677K in Q4 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.